REVB earnings date and last-quarter result: next report 2026-08-07, last quarter miss, P/E -0.09. Updated 2026-07-23.
Revelation Biosciences (REVB) Research Hub
Revelation Biosciences (REVB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.535 USD (-6.73%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.09, market cap 0.00B. This hub links to the full technical, earnings and options research available for REVB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.535 USD (-6.73%) |
| 52-week range | 0.44 USD – 4.06 USD |
| Trend regime | Range |
| 14-day RSI | 81.4 (Overbought) |
| Trailing P/E | -0.09 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-07 |
Available research for REVB
Covered Call on REVB: how it works, illustrative setup around the real 3.54 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on REVB: how it works, illustrative setup around the real 3.54 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on REVB: how it works, illustrative setup around the real 3.54 USD price, max profit/loss, breakeven and when to use it. Educational.
REVB technical analysis: range, last 3.535 USD, RSI 81.4, 52w range 0.44 USD–4.06 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is REVB in?
Revelation Biosciences (REVB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is REVB in an uptrend or downtrend?
As of 2026-10-26, REVB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is REVB's trailing P/E ratio?
REVB's trailing P/E is -0.09, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does REVB next report earnings?
REVB is next scheduled to report earnings on 2026-08-07.